Searchable abstracts of presentations at key conferences in endocrinology

ea0012s31 | Controlling the overactive parathyroid | SFE2006

Advances in the surgical management of hyperparathyroidism

Harrison BJ

The gold standard for the surgical cure of primary hyperparathyroidism (PHPT) for many years was cervical exploration under general anaesthetic, identification of 4 parathyroid glands and removal of enlarged/abnormal glands. Despite cure rates in expert hands of 98% with minimal morbidity the surgical management of PHPT is changing.PHPT in most cases (85%) is caused by single gland disease. The advances in preoperative localisation of abnormal parathyroi...

ea0045p25 | Diabetes | BSPED2016

Management of Paediatric Diabetic Ketoacidosis: An Audit

Gollins Charlotte , Javed Muhammad , Muhammad BJ

Introduction: NICE Guidelines NG18 (published 2015) advocate a more conservative approach to management of diabetic ketoacidosis (DKA) in children and young people up to the age of 18, in an attempt to reduce the risk of cerebral oedema.We aimed to assess if management of DKA in children at Manor Hospital was compliant with hospital guidelines, that were based on BSPED guidelines (issued 2009). We analysed the difference in total fluid administered if th...

ea0070aep750 | Pituitary and Neuroendocrinology | ECE2020

Country-specific differences in adult growth hormone deficiency diagnosis and treatment rates

Nedjatian Navid , den Hollander Bjørnar , Amirouche Yacine

Background: Adult growth hormone deficiency (AGHD) is a rare disease associated with adverse metabolic abnormalities and possibly increased cardiovascular morbidity and mortality. Although basic prevalence data is available, little is known about the rates of diagnosed and treated patients.Aim: To understand the rates of AGHD diagnosis/treatment and details about patients’ growth hormone (GH) dose, age and treatment duration....

ea0014s12.2 | Hypothalamic network controlling food intake | ECE2007

Neurotransmitter content of orexigenic and anorexigenic neurones

Meister Björn , Dürr Katrin , Norsted Ebba

During the last two decades attention has been focused on the role of different neuropeptides in hypothalamic control of feeding behavior. Se-veral hypothalamic peptides that participate in the control of ingestive behavior are produced in neuronal cell bodies of the arcuate nucleus and/or the lateral hypothalamic area. Apart from producing orexigenic or anorexigenic compounds of peptidergic nature, it has recently become apparent that these neurons also produce several classi...

ea0011oc23 | Clinical endocrinology | ECE2006

Improved Prognosis in Midgut Carcinoid patients by treating raised circulating Neurokinin A (NKA)

Ardill JES , Johnston BJ , Turner GB , McGinty A , McCance DR

Midgut Carcinoid disease (MGC) is uncommon, occurring in approximately 1.4 per 100,000 of the population per year. MGC has an unpredictable disease progression varying from rapid and aggressive to slow and indolent. For this reason it is not appropriate to treat all patients according to the same schedule. As some treatments are not without risk, it is important to identify those patients selected for these options at an appropriate stage of disease.In a...

ea0019p356 | Thyroid | SFEBES2009

Levothyroxine and iron in pregnancy: right dose, wrong time?

Ng JM , Wakil A , Dawson A , Masson EA , Allan BJ , Lindow SW , Krishnan R , Wardell S , Igzeer Y

Background: Absorption of levothyroxine is significantly reduced in the presence of oral iron if these two medications are ingested simultaneously, possible as a result of the formation of an insoluble complex with these 2 medications. Ideally all hypothyroid pregnant women on thyroid replacement therapy should be advised to avoid simultaneous ingestion of levothyroxine and iron containing medicines.Patients and methods: We conducted a retrospective obse...

ea0011p765 | Steroids | ECE2006

NaB affect the local regulation of vitamin D in colorectal cancer

Ogunkolade BW , Khalaf S , Boucher BJ , Davis D , Dorudi S , Jenkins PJ , Bustin SA

Introduction: The development of colorectal cancer is influenced by dietary as well as growth factors. Butyrate, (NaB) one of the metabolic by-products of bacterial fermentation of dietary fibre is a primary source of energy for colonic mucosa. It has growth-promoting effects on normal colonic epithelial cells, induces cell cycle arrest, differentiation and apoptosis in colorectal cancer cells. Since it has been suggested that the apoptotic effects of NaB may be due to its syn...

ea0014p245 | (1) | ECE2007

Growth hormone Reduces Inflammation in Postmenopausal Women with Abdominal Obesity: a 12-month randomized placebo-controlled trial

Franco Celina , Andersson Björn , Lönn Lars , Bengtsson Bengt-Æke , Svensson Johan , Johannsson Gudmundur

Context: Abdominally obese individuals have relative hyposomatotropism, elevated serum markers of inflammation, and increased risk of cardiovascular disease (CVD).Objective: The aim was to study the effect of GH treatment on serum levels of inflammatory markers and vascular adhesion molecules in postmenopausal women with abdominal obesity.Design: Forty postmenopausal women aged 51–63 yrs with abdominal obesity received GH (0.6...

ea0070aep180 | Bone and Calcium | ECE2020

Baseline characteristics from the observational paradighm registry of patients with chronic hypoparathyroidism

L Clarke Bart , Rejnmark Lars , Ing Steven , Luisa Brandi Maria , Björnsdottir Sigridur , Hahner Stefanie , Hofbauer Lorenz C , Houillier Pascal , Khan Aliya A , Levine Michael A , Mannstadt Michael , M Shoback Dolores , Vokes Tamara J , Zhang Pinggao , Marelli Claudio , Germak John , Gittoes Neil

PARADIGHM is an actively recruiting, prospective, observational registry (NCT01922440/EUPAS16927). The primary objective is to evaluate the safety and effectiveness of recombinant human parathyroid hormone, rhPTH(1-84), treatment in patients with chronic hypoparathyroidism under routine clinical care. The secondary objective is tocharacterize the clinical course of chronic hypoparathyroidism under conditions of routine clinical practice. At enrollment, registry inclusion crite...

ea0070aep1 | Adrenal and Cardiovascular Endocrinology | ECE2020

Residual corticosteroid production in autoimmune addison´s disease

Bjorvatn Saevik Åse , Åkerman Anna-Karin , Methlie Paal , Quinkler Marcus , Palmström Jörgensen Anders , Höybye Charlotte , Debowska Aleksandra J , Gunnar Nedrebø Bjørn , Lise Dahle Anne , Carlsen Siri , Tomkowicz Aneta , Therese Sollid Stina , Nermoen Ingrid , Grønning Kaja , Dahlqvist Per , Grimnes Guri , Skov Jakob , Finnes Trine , Valland Susanna F , Wahlberg Jeanette , Emblem Holte Synnøve , Simunkova Katerina , Kämpe Olle , Sverre Husebye Eystein , Bensing Sophie , Øksnes Marianne

Background: Previous research show that autoimmune adrenal insufficiency develops gradually over time and inexorably results in a total inability to produce adrenal steroids. However, growing evidence suggest that a few patients preserve some steroid producing capacity.Aim: To explore the frequency of residual cortisol production and possible clinical consequences in patients with autoimmune Addison´s disease (AAD).Material an...